Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Osamu Komori is a dedicated urologic oncologist whose research focuses on improving risk stratification and predictive modeling for prostate cancer, particularly in high-risk and post-surgical settings. His most cited work, a 2015 study on preoperative predictive factors for biochemical recurrence in clinically localized high-risk prostate cancer (21 citations), established a framework for refining treatment decisions beyond traditional staging. Dr. Komori further advanced the field by demonstrating the prognostic significance of micro-lymphatic invasion and pathological Gleason score in patients with organ-confined disease and negative margins after robot-assisted radical prostatectomy (2019, 9 citations), offering critical insights for postoperative surveillance. More recently, he introduced a novel prostate-specific antigen nomogram using area under the receiver operating characteristic curve boosting (2022, 5 citations), leveraging machine learning to enhance the prediction of advanced disease. His cumulative work, spanning from surgical pathology to computational modeling, has contributed to more personalized prognostic tools for prostate cancer patients, helping clinicians identify those most likely to benefit from aggressive therapy or closer monitoring. Dr. Komori’s research continues to bridge the gap between pathological findings and clinical outcomes.